Relates to dihydropyrimidine dehydrogenase deficiency testing
Summary
Requires dihydropyrimidine dehydrogenase deficiency testing prior to fluoropyrmidine or other antimetabolite treatment; requires policies and contracts of insurance to include coverage for dihydropyrimidine dehydrogenase deficiency testing; provides for dihydropyrimidine dehydrogenase deficiency testing under the medical assistance program.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2021
Committee Review
Floor Vote
Governor
Introduced Jan 12, 2021
Last action Jan 5, 2022
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
2
Jan 5, 2022
Committee
REFERRED TO HEALTH
upper
Jan 12, 2021
Committee
REFERRED TO HEALTH
upper
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
NB
Neil Breslin
DDemocratic/Working Families
Ask Maddy
·
AI policy assistant
Ask Maddy about S 1462
Scope: NY
Hi! I can help you understand S 1462. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline